Can Weight Loss Injections Cause Depression?

What regulators concluded after reviewing the evidence

The question of whether weight loss injections affect mental health has been examined formally, not just debated online. In 2023, the European Medicines Agency and the MHRA launched a review of all available data on GLP-1 receptor agonists (including semaglutide and tirzepatide) after reports of suicidal ideation and self-harm reached the pharmacovigilance databases. The review concluded that the available evidence did not confirm a causal relationship between these medicines and depression or suicidal thoughts. Both agencies noted that the background rate of depression in people living with obesity is higher than in the general population, making it methodologically difficult to attribute individual cases to the medicine itself rather than the underlying condition.

The MHRA's Yellow Card scheme continues to collect reports, and prescribers remain alert. This is exactly how post-market surveillance should work for newer medicines carrying the Black Triangle (▼) designation. The absence of a confirmed causal signal is reassuring, but it is not the same as proof that every individual will be unaffected. That distinction matters when a prescriber is weighing up your personal history.

If you are already being treated for depression or anxiety, that is a conversation to have before starting treatment, not something to flag after the fact.

What the trial data showed about mood in participants

Published data from the large phase-3 trials are informative. The SURMOUNT-1 trial of tirzepatide, which randomised 2,539 adults with obesity over 72 weeks, did not find an increase in depressive symptoms in participants on active treatment compared with placebo. The STEP 1 semaglutide trial reported a similar picture. Adverse event reporting in both programmes included psychiatric events, and no significant imbalance emerged.

One nuance worth knowing: many participants in these trials reported improvements in quality-of-life scores, including mood-related domains, alongside weight loss. Some researchers suggest this may partly reflect the psychological relief of seeing meaningful change in a condition that often carries stigma and frustration. That does not mean the medicine improves mood, it means the picture is more complex than a simple cause-and-effect relationship. Our clinical team sees this complexity regularly; no two people's experience is identical.

For a broader look at what is known about side effects and monitoring during treatment, the NHS information on tirzepatide covers the current clinical consensus in plain language.

Mood changes that might occur, and what actually causes them

People do sometimes report changes in mood after starting a weight loss injection, and it is worth thinking carefully about what might be driving that. Significant calorie reduction can itself affect energy and mood, particularly in the early weeks when appetite suppression is strongest. Disrupted sleep from gastrointestinal side effects, the adjustment of stopping certain foods that previously provided comfort, and anxiety about injecting for the first time can all contribute. These are real experiences. They are also largely distinct from a pharmacological effect of the medicine on the brain.

One simple habit that takes under a minute: keep a brief note on your phone each week with a number from one to ten for how you feel overall. It takes seconds, and it gives you something concrete to share with your prescriber at reviews, far more useful than trying to recall a six-week stretch from memory. If numbers start dropping steadily, that is a signal to make contact rather than wait.

Concerns about other physical changes during treatment are common too; our page on hair loss and weight loss injections addresses another frequently asked question about unwanted changes people notice. There are also separate questions about longer-term safety, if you are curious about what the evidence says on other risk areas, the page on weight loss injections and cancer risk covers that evidence in the same thorough way. People also sometimes ask whether these treatments affect body composition in other ways, and if that is on your mind, our page on whether B12 injections can cause weight loss explores that related question in detail.

When to get medical help, and what to tell your prescriber

If you notice persistent low mood, a loss of interest in things that usually matter to you, or any thoughts of self-harm after starting or increasing a dose, contact a healthcare professional the same day. Do not wait for a scheduled review. In the UK, your GP surgery, NHS 111, or the Samaritans (116 123) are all appropriate first contacts depending on urgency. For a mental health crisis, call 999 or go to your nearest A&E.

Pre-existing mental health conditions are part of the clinical assessment at any reputable prescribing service. At nume, a GPhC-registered prescriber reads every consultation personally and considers your full health picture before making any prescribing decision. That includes mental health history, and if you want to understand the full picture of how weight loss injections relate to depression, we have covered the evidence in detail. You can read more about how that process works on our guide to obtaining weight loss injections, or see a broader overview of the treatment options we offer on the weight management page.

If you have questions about a specific situation, speaking to a prescriber directly is always the right move. There is no obligation, and the consultation is free.